Companies Attending VIVE Event 2025

Assure Health provides technology-enabled chronic disease management. They also provide medical devices and a technology platform to provide preventive care through a care manager who works with the customer and their primary doctor. They enable patients to get care for chronic conditions.

AssureCare is a privately-held healthcare technology company that provides innovative care management solutions to commercial and health and human service providers. The company's flagship software platform, MedCompass, is used by healthcare providers throughout the United States to deliver end-to-end care management for millions of patients daily. MedCompass transforms healthcare management by automating processes and streamlining workflows, thus allowing care professionals to make better decisions that dramatically improve the quality of care.

At Astellas, our vision is to be at the forefront of healthcare change by turning innovative science into meaningful VALUE for patients. As a specialty global pharmaceutical company, we focus on accelerating the discovery, development and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. Together with our partners, we aim to lead in the areas where we can deliver the greatest value, with a focus on immuno-oncology, gene therapy, mitochondria, blindness and regeneration and targeted protein degradation. Astellas operates its business in approximately 70 countries around the world. It has approximately 14,000 employees, and its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation. In its FY2022 financial results, revenue achieved about 1,500 billion yen (ca.$11 billion*), and R&D expenses were about 280 billion yen (ca.$2.0 billion*). *The exchange rate for the yen, 1USD: 142yen

At Astellas, our vision is to be at the forefront of healthcare change by turning innovative science into meaningful VALUE for patients. As a specialty global pharmaceutical company, we focus on accelerating the discovery, development and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. Together with our partners, we aim to lead in the areas where we can deliver the greatest value, with a focus on immuno-oncology, gene therapy, mitochondria, blindness and regeneration and targeted protein degradation. Astellas operates its business in approximately 70 countries around the world. It has approximately 14,000 employees, and its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation. In its FY2022 financial results, revenue achieved about 1,500 billion yen (ca.$11 billion*), and R&D expenses were about 280 billion yen (ca.$2.0 billion*). *The exchange rate for the yen, 1USD: 142yen

Provider of mental health treatment services to patients in South Shore, with multiple locations. The team offers medication management and therapy for various mental health conditions, and accepts most commercial insurance plans. Telehealth and in-person treatment options are available with certifications and policies related to privacy and accessibility.

AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. It discovers new medicines that are designed to improve the health and quality of life of patients, offering added benefits such as reduced side effects or better ways of taking the treatment. It focuses on getting the best from every medicine it makes by exploring all the ways it can be used or improved.

Astute Imaging is a healthcare IT solutions company focusing on developing disruptive AI solutions to advance image-guided therapy and procedure planning for cardiovascular and interventional radiology. Astute Imaging will also provide cloud-based AI technologies for medical devices companies to streamline their product development, pre-market approvals, and post-market surveillance.

AT&T is a telecommunications company that provides wireless communications, local exchange, and long-distance services for consumers and businesses in the United States and internationally. The company offers its services in two segments, wireless and wireline. Its wireless segment offers various wireless voice, data, text, and other services. This segment sells various handsets, wirelessly enabled computers, and wireless data cards for personal computers through its owned stores, agents, and third-party retail stores. It also sells accessories comprising carrying cases, hands-free devices, batteries, battery chargers, and other items to consumers as well as to agents and third-party distributors. The company’s wireline segment provides data services such as switched and dedicated transport, DSL internet access, network integration, managed web hosting, packet, and enterprise networking services as well as local, interstate, and international wholesale networking capacity solutions to other service providers. This segment also offers voice services consisting of local and long-distance services, wholesale switched access services to other service providers, and outsourcing and integration services as well as CPE and government-related services.

Developer of a telehealth medication monitoring platform designed to improve medication adherence and treatment outcomes for patients with opioid use disorder. The company's platform monitors treatment between office visits and prescription refills, improving medication adherence, simplifying regulatory compliance, enabling clients to get enhancing treatment outcomes.

Developer of an early warning and monitoring platform designed to predict and prevent clinician burnout and turnover in the healthcare system. The company's platform uses machine learning to predict burnout and turnover, enabling clinicians to identify and prioritize initiatives to increase provider efficiencies and financials.